SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Interim trading statement

3 Aug 2017 07:00

RNS Number : 9666M
Ebiquity PLC
03 August 2017
 

Ebiquity Plc

("the Company")

 

 

Interim trading statement

 

 

Ebiquity plc, the leading independent marketing analytics specialists, today announces its trading statement for the 6 months ended 30 June 2017 ("the period").

 

Ebiquity's total revenues have grown by 5% over the period, with operating profit and earnings anticipated to be in line with market expectations.

 

During the period we continued to deliver against the milestones set out within our Growth Acceleration Plan. As planned, we organically expanded our Marketing Effectiveness practice into Europe and Asian markets, recruited dedicated business development staff in selected markets, and invested into internal support functions.

 

Additionally we launched the Ebiquity "Media Transparency Score" to help advertisers understand how well their business operations perform in achieving the level of media transparency they desire from their marketing activities, and "Total View Attribution" which enables clients to improve the return on investment of their media, by enabling them to understand which media channels and campaigns (both online and offline in combination) are the most effective and warrant increased investment.

 

Revenues from the Media Value Measurement ("MVM") practice achieved high single digit growth, benefitting from strong performance from our Contract Compliance business as clients are more focused on achieving media transparency. However, the performance of our US MVM business was softer than anticipated during the period, due to a lower rate of client renewals. We are in the process of strengthening our US team in response to these changing client demands.

 

The Market Intelligence ("MI") practice revenues from our platform business (Portfolio), which accounts for over 90% of MI revenue, increased over the period. We launched our Portfolio Digital service in Asia Pacific and Europe, which combined with high renewal rates, has driven a return to revenue growth. As expected, revenue from our project based reputation business declined in the first half.

 

Within the Marketing Performance Optimization ("MPO") practice our Marketing Effectiveness revenues continued to grow, most notably from our UK business. Additionally, during the first half of the year in line with our Growth Acceleration Plan we recruited Marketing Effectiveness practice leaders in Germany, France and Singapore. Performance from our US based Multi-Channel Analytics practice fell behind expectations due to organisational changes at some of our largest clients.

 

Whilst the first half of the year has been softer in the US, we anticipate stronger performance from the US MPO and MVM in the second half of the year and we are pleased that the MI practice has returned to growth following high renewal rates and new product launches. Management anticipate that full year trading will be broadly in line with market expectations.

 

The Company will release its interim report for the 6 months ended 30 June 2017 on 26 September 2017.

3 August 2017

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Andrew Noble (CFO)

 

020 7650 9600

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

020 7457 2020

 

Numis Securities Limited

Nick Westlake (NOMAD)

Toby Adcock (Corporate Broker)

 

020 7260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGGRMZFGNZZ
Date   Source Headline
30th May 20193:20 pmRNSHolding(s) in Company
1st May 20197:00 amRNSTotal Voting Rights
30th Apr 201912:30 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSAnnual Report
18th Apr 20193:05 pmRNSIssue of Shares
12th Apr 201910:45 amRNSCorrection - Issue of Shares
9th Apr 20197:00 amRNSIssue of Shares
2nd Apr 201910:55 amRNSDirector/PDMR Shareholding
1st Apr 20194:40 pmRNSIssue of Shares
27th Mar 201912:25 pmRNSDirector/PDMR Shareholding
25th Mar 20192:30 pmRNSCorrection - Dividend payment schedule
25th Mar 20197:00 amRNSUnaudited Preliminary Results
1st Mar 20192:15 pmRNSTotal Voting Rights
22nd Feb 20193:55 pmRNSIssue of Shares
18th Feb 20197:00 amRNSHolding(s) in Company
12th Feb 20197:00 amRNSPre-close Trading Update
1st Feb 20197:00 amRNSTotal Voting Rights
23rd Jan 20194:50 pmRNSReplacement: Issue of Shares
23rd Jan 20193:25 pmRNSIssue of Shares
14th Jan 20193:35 pmRNSIssue of Shares
3rd Jan 20192:55 pmRNSIssue of Shares
2nd Jan 201911:40 amRNSCompletion of the disposal of the AdIntel division
2nd Jan 201911:40 amRNSDirectorate Change
2nd Jan 20197:00 amRNSTotal Voting Rights
14th Dec 20187:00 amRNSDirectorate Change
5th Dec 20181:45 pmRNSIssue of Shares
22nd Nov 20187:00 amRNSStatement re CMA final clearance notification
22nd Nov 20187:00 amRNSTrading Update
1st Nov 20187:00 amRNSTotal Voting Rights
24th Oct 20182:40 pmRNSIssue of Shares
23rd Oct 20182:05 pmRNSHolding(s) in Company
18th Oct 20184:06 pmRNSIssue of Shares
15th Oct 20187:00 amRNSIssue of Shares
11th Oct 20187:10 amRNSStatement re CMA Provisional Findings
10th Oct 201812:15 pmRNSDirectorate Change
4th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSTotal Voting Rights
27th Sep 20189:10 amRNSIssue of Shares
25th Sep 20187:00 amRNSDirectorate Change
25th Sep 20187:00 amRNSInterim Results
3rd Aug 20188:51 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
27th Jul 20188:59 amRNSHolding(s) in Company
27th Jul 20188:55 amRNSHolding(s) in Company
27th Jul 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jul 20187:00 amRNSInterim Trading Update
20th Jul 20185:00 pmRNSHolding(s) in Company
11th Jul 20183:05 pmRNSAward of options
6th Jul 20183:00 pmRNSIssue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.